TradingKey

關於 Transmedics Group Inc 公司

TransMedics Group, Inc. 是一家醫療技術公司，致力於爲患有晚期肺、心和肝功能衰竭的患者提供器官移植療法轉型。該公司專門從事便攜式體外溫灌注和移植捐獻器官評估。其器官護理系統 (OCS) 是一種便攜式器官灌注、優化和監測系統，利用其定製技術在人體外複製捐獻器官的近生理條件。該公司還開發了國家 OCS 計劃 (NOP)，這是一個交鑰匙解決方案，提供外包器官檢索、OCS 器官管理和物流服務，以在美國開展移植計劃。其物流服務包括航空運輸、地面運輸和其他協調活動。其 NOP 提供經過培訓的器官採購外科醫生、臨牀專家和移植協調員，利用其 OCS 技術提供端到端臨牀解決方案。

公司簡介

公司代碼TMDX

公司名稱Transmedics Group Inc

上市日期May 02, 2019

成立日期2018

CEODr. Waleed H. Hassanein, M.D.

員工數量728

證券類型Ordinary Share

年結日May 02

公司地址200 Minuteman Road

城市ANDOVER

上市交易所NASDAQ Global Market Consolidated

國家United States of America

郵編01810

電話19785520900

網址https://www.transmedics.com/

公司代碼TMDX

上市日期May 02, 2019

成立日期2018

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Dr. Waleed H. Hassanein, M.D.

President, Chief Executive Officer, Director

481.61K

-8.98%

Mr. James R. Tobin

Independent Chairman of the Board

177.21K

+1.22%

Dr. David Weill, M.D.

Independent Director

12.13K

+13.06%

Mr. Nicholas (Nick) Corcoran

Senior Vice President - Supply Chain and Operations

7.04K

-44.49%

Ms. Merilee Raines, CPA

Independent Director

4.06K

+110.86%

Ms. Stephanie Lovell

Independent Director

4.06K

+110.86%

Mr. Thomas James Gunderson

Independent Director

4.06K

+110.86%

Mr. Anil Ranganath

Senior Vice President, General Counsel, Corporate Secretary

1.87K

-87.03%

Mr. Gerardo Hernandez

Chief Financial Officer, Treasurer

331.00

-97.93%

Mr. Edwin M. Kania, Jr.

Independent Director

--

名稱

名稱/職務

職務

持股

持股變動

Dr. Waleed H. Hassanein, M.D.

President, Chief Executive Officer, Director

481.61K

-8.98%

Mr. James R. Tobin

Independent Chairman of the Board

177.21K

+1.22%

Dr. David Weill, M.D.

Independent Director

12.13K

+13.06%

Mr. Nicholas (Nick) Corcoran

Senior Vice President - Supply Chain and Operations

7.04K

-44.49%

Ms. Merilee Raines, CPA

Independent Director

4.06K

+110.86%

Ms. Stephanie Lovell

Independent Director

4.06K

+110.86%

收入明細

單位: USD更新時間: 7月6日週日

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

OCS Liver net revenue

108.86M

76.29%

OCS Heart net revenue

29.82M

20.90%

OCS Lung net revenue

4.01M

2.81%

地區USD

名稱

營收

佔比

United States

138.62M

97.15%

All other countries

4.07M

2.85%

業務

地區

業務USD

名稱

營收

佔比

OCS Liver net revenue

108.86M

76.29%

OCS Heart net revenue

29.82M

20.90%

OCS Lung net revenue

4.01M

2.81%

股東統計

更新時間: 5月23日週五

持股股東

股東類型

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

14.15%

Fidelity Management & Research Company LLC

13.67%

The Vanguard Group, Inc.

10.46%

UBS Asset Management (Switzerland)

5.68%

State Street Global Advisors (US)

3.83%

Other

52.20%

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

14.15%

Fidelity Management & Research Company LLC

13.67%

The Vanguard Group, Inc.

10.46%

UBS Asset Management (Switzerland)

5.68%

State Street Global Advisors (US)

3.83%

Other

52.20%

股東類型

持股股東

佔比

Investment Advisor

83.08%

Investment Advisor/Hedge Fund

21.81%

Hedge Fund

6.54%

Research Firm

4.88%

Individual Investor

3.03%

Bank and Trust

2.37%

Pension Fund

1.67%

Sovereign Wealth Fund

1.11%

Family Office

0.06%

機構持股

更新時間: 7月1日週二

報告期間

機構數

持股數

持股佔比

持股變動

2025Q2

744

42.27M

124.93%

-2.23M

2025Q1

751

42.32M

125.08%

-2.32M

2024Q4

728

40.09M

119.11%

-642.74K

2024Q3

673

39.30M

117.10%

+1.37M

2024Q2

615

36.53M

110.85%

-3.27M

2024Q1

544

37.44M

113.97%

-4.28M

2023Q4

512

38.18M

116.94%

-3.46M

2023Q3

482

38.42M

117.77%

-240.92K

2023Q2

462

35.43M

108.88%

-81.81K

2023Q1

431

32.52M

99.99%

-2.56M

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

BlackRock Institutional Trust Company, N.A.

4.83M

14.26%

-61.18K

-1.25%

Mar 31, 2025

Fidelity Management & Research Company LLC

4.66M

13.77%

+708.11K

+17.92%

Mar 31, 2025

The Vanguard Group, Inc.

3.57M

10.54%

-60.92K

-1.68%

Mar 31, 2025

UBS Asset Management (Switzerland)

1.94M

5.73%

+1.07M

+123.65%

Mar 31, 2025

State Street Global Advisors (US)

1.31M

3.86%

-54.72K

-4.02%

Mar 31, 2025

UBS Asset Management (Americas) LLC

1.14M

3.37%

+1.14M

+32899.25%

Mar 31, 2025

Macquarie Investment Management

1.12M

3.3%

+123.10K

+12.40%

Mar 31, 2025

Fidelity International

985.22K

2.91%

+129.87K

+15.18%

Mar 31, 2025

Braidwell LP

854.88K

2.53%

-67.22K

-7.29%

Mar 31, 2025

Hood River Capital Management LLC

795.77K

2.35%

+795.77K

--

Mar 31, 2025

持股ETF

更新時間: 2 小時前

機構名稱

佔比

Global X HealthTech ETF

4.45%

Invesco Dorsey Wright Healthcare Momentum ETF

3.43%

Invesco S&P SmallCap Health Care ETF

3.24%

Innovator IBD 50 Fund ETF

3.1%

SPDR S&P Health Care Equipment ETF

1.71%

Invesco S&P SmallCap 600 Pure Growth ETF

1.53%

First Trust Nasdaq Lux Digi Health Solutions ETF

1.51%

Fidelity Sustainable US Equity ETF

1.25%

BNY Mellon Innovators ETF

1.12%

WisdomTree US SmallCap Quality Growth Fund

0.73%

Global X HealthTech ETF

佔比4.45%

Invesco Dorsey Wright Healthcare Momentum ETF

佔比3.43%

Invesco S&P SmallCap Health Care ETF

佔比3.24%

Innovator IBD 50 Fund ETF

佔比3.1%

SPDR S&P Health Care Equipment ETF

佔比1.71%

Invesco S&P SmallCap 600 Pure Growth ETF

佔比1.53%

First Trust Nasdaq Lux Digi Health Solutions ETF

佔比1.51%

Fidelity Sustainable US Equity ETF

佔比1.25%

BNY Mellon Innovators ETF

佔比1.12%

WisdomTree US SmallCap Quality Growth Fund

佔比0.73%

分紅派息

近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股

公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

Transmedics Group Inc

120.550USD

Transmedics Group Inc

120.550

概覽

公司

財務